listed below are companies who we know can cover terminal conditions. As mentioned, there are lots of things that go towards the premium and acceptance criteria (for customers with or without medical conditions) such as duration of trip, location, other medical conditions and time until travel date so It cant […]
Articles from Guardian news paper on IPF.
Have you or a loved one been diagnosed with Idiopathic Pulmonary Fibrosis (IPF)? If so, we would like to know your views on IPF care in the UK. In July 2015, Action for Pulmonary Fibrosis (APF) conducted its first patient survey to assess the extent to which the NICE guidelines […]
ILD highlights from the ERS 2017 Congress, 9th September – 13th September in Milan, Italy. The presentation covers progress, new clinical trails, research updates and insights from experts in the field.
Roche’s new Esbriet tablet formulation has been approved for testing in Europe. The attached media release covers further details on the approval.
Help raise funds for IPF research & care. Learn more about how you can organise your own fundraising events to support ILD.
Organise your own tea or coffee catchup! Share experiences, advice or tips for living with IPF.
